Related Experiment Video
Updated: Mar 27, 2026
13:05
Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
Published on: June 28, 2019
8.9K
A dynamic Asp-Arg interaction is essential for catalysis in microsomal prostaglandin E2 synthase
Joseph S Brock1, Mats Hamberg1, Navisraj Balagunaseelan1
1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden;
Summary
Microsomal prostaglandin E2 synthase type 1 (mPGES-1) is crucial for inflammation. Researchers found Arg-126 and Asp-49, not Ser-127, are key for mPGES-1 activity, guiding new drug development.
Area of Science:
- Biochemistry
- Enzymology
- Structural Biology
Background:
- Microsomal prostaglandin E2 synthase type 1 (mPGES-1) synthesizes prostaglandin E2, a key mediator in inflammatory conditions.
- mPGES-1 is a significant drug target for anti-inflammatory and anticancer therapies.
- A recent crystal structure proposed Ser-127's role in stabilizing glutathione (GSH) thiolate formation.
Purpose of the Study:
- To investigate the functional roles of putative catalytic residues in mPGES-1 activity.
- To clarify the catalytic mechanism of mPGES-1, particularly the role of Ser-127, Arg-126, and Asp-49.
- To correlate structural dynamics with biochemical data for a deeper understanding of enzyme function.
Main Methods:
- Site-directed mutagenesis was employed to alter specific amino acid residues.
- Enzyme activity assays were performed to measure the catalytic function of mutant mPGES-1.
- Structural dynamics analysis, including examination of conformational ensembles, was utilized.
Main Results:
- Ser-127 was found to be non-essential for mPGES-1 activity.
- An interaction between Arg-126 and Asp-49 was identified as critical for catalysis.
- A crystallographic water molecule, stabilized by Arg-126 and influenced by Asp-49, acts as a general base in GSH thiolate formation.
- Hidden conformational ensembles correlated with biochemical findings, revealing a ligand-dependent signaling network.
Conclusions:
- The catalytic mechanism of mPGES-1 involves an Arg-126/Asp-49 interaction and a catalytic water molecule, rather than Ser-127.
- Understanding this mechanism provides insights into mPGES-1 function and potential drug interactions.
- These findings have significant implications for the rational design of novel mPGES-1 inhibitors for therapeutic applications.
Related Concept Videos
01:14Drug Metabolism: Phase II Reactions
5.6K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.6K
01:19Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
1.2K
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
1.2K
01:48ATP Synthase: Mechanism
18.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.8K
01:19Allosteric Proteins-ATCase
6.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K
02:17Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
4.0K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
4.0K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
598
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
598